Does a low-carbohydrate diet help against brain problems in ageing?
A ketogenic diet produces a modest but measurable improvement on thinking and memory tests in people with mild cognitive decline or Alzheimer's disease. The effects are real but no miracle cure; discuss this with your doctor, especially because the diet can affect your blood fats.
In people with mild cognitive problems or Alzheimer's disease, a ketogenic diet shows measurable but modest improvements on memory and thinking tests. Many studies combined, covering 587 participants across fourteen controlled studies, show a clear effect, and in people with Alzheimer's the score on a widely used dementia test rose by an average of just over 1 point more than in the comparison group. That is noticeable on a test, but still limited in everyday life.
A small study in healthy people with excess weight found that after 3 weeks of ketogenic eating, blood flow in the brain increased by 22%, and a substance that supports brain growth rose by 47%. That combination is biologically interesting, but the study included only 11 participants, making it an early signal rather than firm evidence.
An approach combining a plant-based ketogenic diet with intermittent fasting kept cognitive decline clearly at bay in a small 6-month study of people with Alzheimer's disease: 93% of participants in the intervention group remained stable or improved, compared with 70% in the comparison group. How well someone responds depends strongly on their individual metabolic profile.
A few practical points are worth noting. In people with Alzheimer's, the ketogenic diet raised LDL cholesterol by an average of 0.31 mmol/L and triglycerides by 0.19 mmol/L, which deserves attention for heart health. Digestive complaints are the most commonly reported side effect. Participants with neurocognitive conditions lost an average of just over 3 kg, which may be undesirable in frail older adults. Have your blood fats checked regularly and discuss this diet with your doctor.
For psychiatric conditions such as schizophrenia, the evidence is still too early-stage to draw conclusions: there are mainly individual case reports and barely any controlled studies. Researchers also point out that the brain as a whole responds in more complex ways than a simple shift in fuel use, and whether that shift also leads to better brain function during ageing remains uncertain.
This answer draws on many studies combined, including two covering hundreds of participants, supplemented by a small crossover study with 11 participants and an ongoing study with 38 patients. The two larger analyses in Alzheimer's disease are the most robustly supported. The smaller studies and animal studies are preliminary. The researchers themselves noted considerable variation between studies, meaning effects can differ greatly from person to person. The researchers behind the 2020 overview study caution that many studies are small and vary considerably in their methods.